• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ITF2357 干预 HL-60 模型中的细胞凋亡和炎症通路:一项基因表达研究。

ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.

机构信息

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S Chiara, Via Roma 67, 56126 Pisa, Italy.

出版信息

Anticancer Res. 2010 Nov;30(11):4525-35.

PMID:21115902
Abstract

BACKGROUND

Cytotoxic and pro-apoptotic effects exerted by the histone deacetylase inhibitor ITF2357 have been reported in acute myeloid leukemia HL-60 cells. In the current study, its mechanism of action was investigated at the molecular level.

MATERIALS AND METHODS

Cell proliferation was evaluated by methyl thiazol tetrazolium bromide reduction; apoptosis by annexin V, mitochondrial transmembrane potential by tetramethylrhodamine ethyl ester. Functional experiments and gene expression evaluations were performed by flow cytometry, microarray, and quantitative polymerase chain reaction.

RESULTS

Significant cell growth inhibition and increased apoptosis were observed. ITF2357 reduced protein levels of BCL-2, MCL-1, and BCL-X, and increased levels of BAK. Exposure to ITF2357 did not abrogate NF-κB DNA binding. After microarray analysis, interleukin-10, interleukin-6, epidermal growth factor, peroxisome proliferator-activated receptor (PPAR), transforming growth factor β, P38 mitogen-activated protein kinase, aryl hydrocarbon receptor, xenobiotic metabolism, PPAR/retinoic acid receptor, NF-κB, apoptosis, lipopolysaccharide/interleukin-1, G-protein receptor, T-cell receptor, and platelet-derived growth factor were the de-regulated pathways.

CONCLUSION

This study shows that ITF2357 influences both proliferation and inflammatory pathways in HL-60 cells; this observation could have possible applications in clinical practice.

摘要

背景

组蛋白去乙酰化酶抑制剂 ITF2357 在急性髓系白血病 HL-60 细胞中已被报道具有细胞毒性和促凋亡作用。在本研究中,从分子水平研究了其作用机制。

材料和方法

通过噻唑蓝溴化还原法评估细胞增殖;通过膜联蛋白 V 评估细胞凋亡;通过四甲基罗丹明乙酯评估线粒体跨膜电位。通过流式细胞术、微阵列和实时定量聚合酶链反应进行功能实验和基因表达评估。

结果

观察到明显的细胞生长抑制和凋亡增加。ITF2357 降低了 BCL-2、MCL-1 和 BCL-X 的蛋白水平,增加了 BAK 的水平。ITF2357 暴露并没有消除 NF-κB 的 DNA 结合。经过微阵列分析,白细胞介素-10、白细胞介素-6、表皮生长因子、过氧化物酶体增殖物激活受体(PPAR)、转化生长因子-β、P38 丝裂原激活蛋白激酶、芳香烃受体、外来化合物代谢、PPAR/视黄酸受体、NF-κB、凋亡、脂多糖/白细胞介素-1、G 蛋白受体、T 细胞受体和血小板衍生生长因子是失调的途径。

结论

本研究表明 ITF2357 影响 HL-60 细胞的增殖和炎症途径;这一观察结果可能在临床实践中有潜在的应用。

相似文献

1
ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.ITF2357 干预 HL-60 模型中的细胞凋亡和炎症通路:一项基因表达研究。
Anticancer Res. 2010 Nov;30(11):4525-35.
2
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line.
Leukemia. 2009 Oct;23(10):1935-8. doi: 10.1038/leu.2009.119. Epub 2009 Jul 23.
3
[ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].[ITF-2357对髓系白血病细胞系细胞体外增殖的抑制作用及其机制]
Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):366-70.
4
Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.组蛋白去乙酰化酶抑制剂通过阻断核因子κB信号传导诱导人嗜T淋巴细胞病毒1型感染的T细胞生长停滞和凋亡。
Leuk Res. 2008 Feb;32(2):287-96. doi: 10.1016/j.leukres.2007.05.026. Epub 2007 Jul 20.
5
Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray.利用cDNA微阵列技术对云芝PSP诱导人早幼粒细胞白血病HL-60细胞凋亡进行分子特征分析。
Int J Oncol. 2005 Aug;27(2):513-23.
6
Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.三氧化二砷联合硼替佐米对HL60细胞系及骨髓增殖性疾病患者原代胚细胞的协同抗增殖作用
Cancer Genet Cytogenet. 2010 Jun;199(2):110-20. doi: 10.1016/j.cancergencyto.2010.02.010.
7
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.人视网膜母细胞瘤细胞系中组蛋白去乙酰化酶抑制的分子后遗症:临床意义
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4072-9. doi: 10.1167/iovs.09-3517. Epub 2009 Apr 22.
8
Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways.丁酸盐和丙酸盐通过 HDAC 抑制剂活性诱导激活或非激活的中性粒细胞凋亡,但不激活 GPR-41/GPR-43 途径。
Nutrition. 2010 Jun;26(6):653-61. doi: 10.1016/j.nut.2009.07.006. Epub 2009 Dec 8.
9
Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.组蛋白去乙酰化酶抑制剂协同增强人 T 细胞急性淋巴细胞白血病细胞死亡受体 4 介导的凋亡细胞死亡。
Apoptosis. 2010 Oct;15(10):1256-69. doi: 10.1007/s10495-010-0521-9.
10
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.LBH589 单药或联合化疗在人急性淋巴细胞白血病异种移植模型中的临床前活性。
Leukemia. 2012 Jul;26(7):1517-26. doi: 10.1038/leu.2012.31. Epub 2012 Feb 6.

引用本文的文献

1
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening.通过高通量药物筛选确定组蛋白去乙酰化酶抑制剂吉维司他(ITF2357)在CRLF2重排的儿童B细胞前体急性淋巴细胞白血病中的协同药物相互作用。
Heliyon. 2024 Jul 3;10(13):e34033. doi: 10.1016/j.heliyon.2024.e34033. eCollection 2024 Jul 15.
2
Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management.血液系统疾病中抗肿瘤治疗的心血管毒性:聚焦改善治疗管理的分子机制
J Clin Med. 2024 Mar 9;13(6):1574. doi: 10.3390/jcm13061574.
3
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
组蛋白去乙酰化酶抑制剂 ITF2357(givinostat)可逆转体外和体内人胶质母细胞瘤模型中的转化表型并拮抗干性。
J Cancer Res Clin Oncol. 2019 Feb;145(2):393-409. doi: 10.1007/s00432-018-2800-8. Epub 2018 Nov 24.
4
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells.自噬途径的抑制协同增强了吉维司他(ITF2357)对人胶质母细胞瘤癌症干细胞的细胞毒活性。
Front Mol Neurosci. 2016 Oct 27;9:107. doi: 10.3389/fnmol.2016.00107. eCollection 2016.
5
Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.硼替佐米与三氧化二砷对一种骨髓增生异常细胞系(P39)的活性:一项基因表达研究
Turk J Haematol. 2015 Sep;32(3):206-12. doi: 10.4274/tjh.2014.0058.
6
Deregulated Levels of the NF-κB1, NF-κB2, and Rel Genes in Ukrainian Patients with Leukemia and Lymphoma in the Post-Chernobyl Period.切尔诺贝利事故后时期乌克兰白血病和淋巴瘤患者中NF-κB1、NF-κB2和Rel基因水平失调
Turk J Haematol. 2016 Mar 5;33(1):8-14. doi: 10.4274/tjh.2014.0190. Epub 2015 Apr 27.